ebola

Documents about ebola

• A simple mathematical model for Ebola in Africa#990198University of Pretoria Repository
• Ebola virus disease: A persistent challenge in global health security.#323262NCBI PubMed Central
• Effect of Ebola Progression on Transmission and Control in Liberia#383884CiNii
• Integrating ecological and anthropogenic risk identifies emerging Ebola spillover hotspots#475764Europe PMC
• Efficacy in Emergency Legal Preparedness Underlying the 2014 Ebola Outbreak#1021707Texas A&M Law Scholarship
• The Ebola Virus and West Africa: Medical and Sociocultural Aspects#497371ScholarSpace
• Cote d'Ivoire - AFRICA- P147740- Health Systems Strengthening and Ebola Preparedness Project - Procurement Plan#8634World Bank
• Cote d'Ivoire - AFRICA- P147740- Health Systems Strengthening and Ebola Preparedness Project - Procurement Plan#8661World Bank
• A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants#160177ClinicalTrials.gov
• Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults#346967ClinicalTrials.gov
• Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - DRC#832313ClinicalTrials.gov
• إرشادات منظمة الصحة العالمية بشأن فعاليات التجمعات الحاشدة التي يحضرها أفراد قادمون من مناطق وُثِّق رصد فيروس بونديبوغيو فيها، أيار/ مايو 2026#349393WHO IRIS
• A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland#279568ClinicalTrials.gov
• The Diagnostic testing for Ebola disease and Marburg virus disease: interim guidance, 9 July 2026#369343World Health Organization
• Age-structured modelling of Ebola convalescence and re-emergence risk: a Bayesian approach#451918Europe PMC
• WHO emergency guidance on the use of licensed Ebola vaccine during Bundibugyo virus disease outbreaks,...#632341World Health Organization
• VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults#668851ClinicalTrials.gov
• WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks,...#237670World Health Organization
• Ebola virus disease in the Democratic Republic of the Congo, 1976-2014: Figures and Data#304852LSHTM Data Compass
• Remdesivir from failed Ebola drug to first FDA-approved COVID-19 antiviral: The medico-legal integration.#399831NCBI PubMed Central
• Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy#880309ClinicalTrials.gov
• A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants#411247ClinicalTrials.gov
• Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health#152499ClinicalTrials.gov
• A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants#174973ClinicalTrials.gov
• Shifting patterns of importation risk of Bundibugyo Ebola virus disease to Europe under outbreak expansion scenarios#337054bioRxiv / medRxiv
• Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure#633765ClinicalTrials.gov
• Estimation of the size of the Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo#928220PubMed Central
• Hippo signalling as a nexus in host–virus interactions#275950PLOS
• High-Resolution Mapping of Environmental Suitability for Reported Ebola Spillover Events in Uganda to Inform Surveillance and Preparedness.#465115NCBI PubMed Central
• Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers#152476ClinicalTrials.gov
• Translational Research Group: Ebola 100 Project#939435QDR Main Collection Dataverse OAI Archive
• A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers#136434ClinicalTrials.gov
• A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)#238174ClinicalTrials.gov
• PREIS: A Modular, Reproducible and AI-Assisted Framework for Epidemic Intelligence Workflows in Africa#270376OSF
• Investigating the perspectives of Liberian frontline health workers on ethical tensions experienced during the Ebola epidemic and the COVID-19 pandemic#445507Europe PMC
• Cost-effectiveness of geographically targeted versus ring vaccination campaigns in response to an outbreak of Ebola Virus Disease caused by Orthoebolavirus zairense#474703bioRxiv / medRxiv
• "Blame the bats again": YouTube reactions to the 2026 Ebola public health emergency reveal mistrust, misinformation, and geopolitical anxiety#478039bioRxiv / medRxiv
• Weekly External Situation Report 18, Data as of 13 September 2026 - Democratic Republic of the Congo and Uganda#928986WHO IRIS
• Infection prevention and control measures for Ebola disease and their outcomes from the perspective of health care workers: a mixed-methods study.#219094NCBI PubMed Central
• It’s not just virology: The Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda demands a wider public health response#414190African Journals Online
• The Uganda - Democratic Republic of the Congo cross-border collaboration for Bundibugyo Ebola response: A new model for African health security, sovereignty and solidarity.#437254NCBI PubMed Central
• A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults#668860ClinicalTrials.gov
• Network-based modelling of Bundibugyo Ebola virus disease importation and spread in Uganda using Displacement Tracking Matrix flow data and non-pharmaceutical intervention compliance scenarios#398144bioRxiv / medRxiv
• Weekly External Situation Report 09, Data as of 12 July 2026 - Democratic Republic of the Congo and Uganda#369345WHO IRIS
• Assessment and management of health and care workers with possible occupational exposures to Orthoebolavirus or Orthomarburgvirus: implementation guidance#216366WHO IRIS
• When it could have been prevented: A maternal death from postpartum hemorrhage due to genital tract lesions complicated by urinary fistula in an Ebola treatment unit in DR Congo.#340682NCBI PubMed Central
• Infection prevention and control considerations for routine immunization activities during the Bundibugyo virus disease outbreak: interim guidance, 21 August 2026#484366WHO IRIS
• Handbook for the management of public health events in air transport: updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus#192285WHO IRIS
• BURIAL, MOURNING, AND THE SOCIAL ORGANIZATION OF CARE IN THE 2026 BUNDIBUGYO VIRUS DISEASE OUTBREAK IN THE DEMOCRATIC REPUBLIC OF THE CONGO A desk-based qualitative synthesis#453227OSF
• Acquisition des kits, équipements et matériel informatique pour les épidémiologistes et les équipes de riposte contre le virus Ebola — Health Security Program in Western and Central Africa - Phase III (Western and Central Africa)#783017World Bank